Health Canada announced on September 21, 2011 that Bayer resume sales of Trasylol.  The company had suspended sales of Trasylol after evidence of a higher rate of death among Trasylol patients in a clinical study. Read more »

On August 16, 2011 the United States Judicial Panel on Multidistrict Litigation ordered that all pending federal cases involving injuries or deaths alleged to have been caused by the use of Darvocet, Darvon or generic Propoxyphene would be consolidated in MDL 2226. The Court accepted the defendants first choice of the Eastern District of Kentucky as site of the MDL. Read more »

According to a market research study prepared by GlobalData, in 2009 DePuy held a 21% market share of the global hip and knee replacement market. This leads to the conclusion that as many 1 in 5 hip implant recipients have had DePuy devices installed and are now subject to the recall. Read more »

The denture cream litigation, in which more than 35 million Americans may be effected has moved closer to trial after attorneys appeared in court to discuss discovery issues. Read more »

A study involving 18,700 Quebec residents aged 65 and older with cataracts and 187,000 age-matched Quebec residents without cataracts, found that people taking SSRIs were 15 percent more likely to be diagnosed with cataracts than those not taking these drugs. Read more »